Designation expands the availability of Tasso+ for decentralized clinical trials, home diagnostic testing, wellness, and anti-doping uses to the European Union.
TassoOne Plus expands signature line of patient-centric healthcare solutions for decentralized clinical trials and home diagnostic testing initiatives.